To assess alternative pathways that may drive BCC tumor growth, we reanalyzed our bulk-level RNA-sequencing (RNA-seq) data of 14 matched tumor-normal pairs of advanced and SMO inhibitor-resistant BCC samples (22, 48). Here, SMO is linked to skin basal cell carcinoma.